Sort
172,184 grants matching “inflammation”
Eradicating Latent SIV from the CNS by CCR5 Inhibition
$740,857Joseph L Mankowski · Johns Hopkins University · R01 · FY2016 · NS
Eradicating Latent SIV from the CNS by CCR5 Inhibition
$740,857Joseph L Mankowski · Johns Hopkins University · R01 · FY2017 · NS
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$740,856Petros C Karakousis · Johns Hopkins University · R01 · FY2023 · AI
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
$740,837Benjamin George Keselowsky · University Of Florida · R01 · FY2025 · AI
Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study
$740,757Stephen Sidney · Kaiser Foundation Research Institute · R01 · FY2017 · HL
mTOR as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target
$740,743David C Fajgenbaum · University Of Pennsylvania · R01 · FY2019 · HL
Probing The Dark Matter of the Genome in the NHLBI Family Heart Study
$740,725Michael A Province · Washington University · R01 · FY2015 · HL
SIV-induced Inflammation Causes Functional Impairment of the PNS
$740,714Joseph L Mankowski · Johns Hopkins University · R01 · FY2017 · NS
SIV-induced Inflammation Causes Functional Impairment of the PNS
$740,714Joseph L Mankowski · Johns Hopkins University · R01 · FY2019 · NS
SIV-induced Inflammation Causes Functional Impairment of the PNS
$740,714Joseph L Mankowski · Johns Hopkins University · R01 · FY2018 · NS
ILC2s as drivers of lung dysfunction in response to early-life inflammation
$740,709Anna E Beaudin · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$740,687Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2025 · HL
Training Program in Environmental Toxicology
$740,637F Peter Guengerich · Vanderbilt University · T32 · FY2022 · ES
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$740,622Karl T Kelsey · Brown University · R01 · FY2021 · CA
INTEGRATIVE PHARMACOGENOMICS OF LEUKOTRIENE INHIBITION IN ASTHMA
$740,588Kelan G Tantisira · Brigham And Women'S Hospital · R01 · FY2009 · HL
PAR2 Pepducins as a Novel Treatment of Idiopathic Pulmonary Fibrosis
$740,572Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2020 · HL
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
$740,540Cassianne Robinson-Cohen · Vanderbilt University Medical Center · R01 · FY2022 · DK
Gut barrier function in Alzheimerâs disease
$740,468Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2024 · AG
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard
$740,416Rajiv Ravindra Mohan · University Of Missouri-Columbia · U01 · FY2022 · EY
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing
$740,400Hani A Awad · University Of Rochester · UH3 · FY2022 · TR
Center for Childhood Asthma in the Urban Environment
$740,395Johns Hopkins University · P01 · FY2004 · ES
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
$740,394Michael John Evans · University Of California, San Francisco · R01 · FY2022 · AI
Transcriptome resources for comparative primate models of lentivirus infection
$740,376Guido Silvestri · Emory University · R24 · FY2014 · OD
Inflammation in human obesity and type 2 diabetes
$740,375Barbara Susanne Nikolajczyk · Boston University Medical Campus · R01 · FY2016 · DK
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
$740,348Kyung W Lee · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK